Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 1 year.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xeris Biopharma Holdings Inc. June 4, 202597.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +24,193 | — | — |
| Mar 30, 2026 | Xeris Biopharma Holdings Inc. | Open-market sale | −10,834 | $5.54 | $60,020 |
| Mar 28, 2025 | Xeris Biopharma Holdings Inc. | Grant or award | +100,000 | — | — |
Questions about James Aloysius Brady
What boards is James Aloysius Brady on?
James Aloysius Brady sits on the board of Xeris Biopharma Holdings Inc.
How long has James Aloysius Brady served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.